Prabin Sharma, MD
Internal Medicine · Bridgeport, CTNPI 1982953956
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,414 of the $4,398 with a category attached, or 77.6%. 14 manufacturers reported payments, led by Olympus Corporation Of The Americas at 46.6% of the total. Among internal medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $87.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$2K
- Boston Scientific$901
- Ovesco Endoscopy USA, Inc.$731
- Cook Medical LLC$175
- Olympus America Inc.$138
- Lumendi LLC$95
- plus $308 from 8 others
What the payments were for
- Travel & lodging$3,41478%
- Food & beverage$98522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 19 | $2,050 |
| Boston Scientific | 12 | $901 |
| Ovesco Endoscopy USA, Inc. | 1 | $731 |
| Cook Medical LLC | 2 | $175 |
| Olympus America Inc. | 2 | $138 |
| Lumendi LLC | 1 | $95 |
| Fujifilm Healthcare Americas Corporation | 3 | $94 |
| Ardelyx, Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| AbbVie | 1 | $24 |
| Apollo Endosurgery US Inc | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,398 in reported general payments places this provider in the 90th percentile of 2,067 internal medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 18 | $3,409 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 14 | $838 |
| Pantoprazole Sodium | 18 | $213 |
| Omeprazole | 12 | $50 |
| Levofloxacin | 26 | $30 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bridgeport
- Nicholas DainiakBridgeport$352K
- Adrian KlufasBridgeport$17K
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$1.6M
- Arthur DecillisMadison$1M
- Charles MontanoCromwell$970K
- Gary BlickNorwalk$683K
- Scott GottliebStamford$508K
- Jeffrey KatzOxford$361K
- Thomas PellechiGreenwich$196K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.